Surrogate Imaging Endpoints

Technical advances in MRI and greater proliferation of other imaging technologies have allowed better evaluation of pharmaceuticals in the early stages of development and have provided a means to objectively demonstrate targeting of drugs and quantitatively measure dosing.  

With these advances and the FDA's acceptance and recognition of the value of "surrogate" imaging endpoints, modern imaging techniques have increasingly become an important part of the drug development process.  

To more quickly determine efficacy of their products, and thus accelerate the FDA approval process, sponsors of pharmaceutical and medical device research seek these endpoints in an accurate and reproducible manner.

Back